Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Cristina Silva Pinto

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Hematology, Transfusion and Cell Therapy|May 2, 2025
Optimization of hydroxyurea in sickle cell disease in BrazilClarisse Lobo, Ana Cristina Silva-Pinto, Rodolfo Delfini Cançado
The Indian Journal of Medical Research|November 18, 2011
Pathophysiological insights in sickle cell diseaseMarie-Hélène Odièvre, Emmanuelle Verger, Ana Cristina Silva-Pinto, et al.
FEMS Immunology and Medical Microbiology|May 19, 2011
Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusionsSvetoslav N Slavov, Simone Kashima, Ana Cristina Silva Pinto, et al.
Canadian Journal of Microbiology|January 28, 2012
Genotyping of Human parvovirus B19 among Brazilian patients with hemoglobinopathiesSvetoslav Nanev Slavov, Simone Kashima, Ana Cristina Silva-Pinto, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|January 8, 2013
Molecular and clinical evaluation of the acute human parvovirus B19 infection: comparison of two cases in children with sickle cell disease and discussion of the literatureSvetoslav Nanev Slavov, Simone Kashima, Ana Cristina Silva-Pinto, et al.
Acta Haematologica|December 5, 2014
Hydroxyurea increases plasma concentrations of microparticles and reduces coagulation activation and fibrinolysis in patients with sickle cell anemiaDenise Menezes Brunetta, Gil Cunha De Santis, Ana Cristina Silva-Pinto, et al.
The New Microbiologica|November 12, 2014
No evidence of xenotropic murine leukemia virus-related virus infection in Brazilian multiply transfused patients with sickle cell disease and beta-thalassemia majorSvetoslav Nanev Slavov, Katia Kaori Otaguiri, Mayra Dorigan Macedo, et al.
Journal of Medical Virology|August 30, 2012
Molecular and phylogenetic analyses of human Parvovirus B19 isolated from Brazilian patients with sickle cell disease and β-thalassemia major and healthy blood donorsSvetoslav Nanev Slavov, Simone Kashima Haddad, Ana Cristina Silva-Pinto, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 21, 2019
Molecular prevalence and genotypes of human pegivirus-1 (HPgV-1) and SENV-like viruses among multiply transfused patients with beta-thalassemiaRafael Dos Santos Bezerra, Elaine Vieira Santos, Roberta Maraninchi Silveira, et al.
Revista Brasileira De Hematologia E Hemoterapia|January 17, 2013
Hematological differences between patients with different subtypes of sickle cell disease on hydroxyurea treatmentFabia Neves, Osvaldo Alves Menezes Neto, Larissa Bueno Polis, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Hematology, Transfusion and Cell Therapy|May 2, 2025
Optimization of hydroxyurea in sickle cell disease in BrazilClarisse Lobo, Ana Cristina Silva-Pinto, Rodolfo Delfini Cançado
The Indian Journal of Medical Research|November 18, 2011
Pathophysiological insights in sickle cell diseaseMarie-Hélène Odièvre, Emmanuelle Verger, Ana Cristina Silva-Pinto, et al.
FEMS Immunology and Medical Microbiology|May 19, 2011
Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusionsSvetoslav N Slavov, Simone Kashima, Ana Cristina Silva Pinto, et al.
Canadian Journal of Microbiology|January 28, 2012
Genotyping of Human parvovirus B19 among Brazilian patients with hemoglobinopathiesSvetoslav Nanev Slavov, Simone Kashima, Ana Cristina Silva-Pinto, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|January 8, 2013
Molecular and clinical evaluation of the acute human parvovirus B19 infection: comparison of two cases in children with sickle cell disease and discussion of the literatureSvetoslav Nanev Slavov, Simone Kashima, Ana Cristina Silva-Pinto, et al.
Acta Haematologica|December 5, 2014
Hydroxyurea increases plasma concentrations of microparticles and reduces coagulation activation and fibrinolysis in patients with sickle cell anemiaDenise Menezes Brunetta, Gil Cunha De Santis, Ana Cristina Silva-Pinto, et al.
The New Microbiologica|November 12, 2014
No evidence of xenotropic murine leukemia virus-related virus infection in Brazilian multiply transfused patients with sickle cell disease and beta-thalassemia majorSvetoslav Nanev Slavov, Katia Kaori Otaguiri, Mayra Dorigan Macedo, et al.
Journal of Medical Virology|August 30, 2012
Molecular and phylogenetic analyses of human Parvovirus B19 isolated from Brazilian patients with sickle cell disease and β-thalassemia major and healthy blood donorsSvetoslav Nanev Slavov, Simone Kashima Haddad, Ana Cristina Silva-Pinto, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 21, 2019
Molecular prevalence and genotypes of human pegivirus-1 (HPgV-1) and SENV-like viruses among multiply transfused patients with beta-thalassemiaRafael Dos Santos Bezerra, Elaine Vieira Santos, Roberta Maraninchi Silveira, et al.
Revista Brasileira De Hematologia E Hemoterapia|January 17, 2013
Hematological differences between patients with different subtypes of sickle cell disease on hydroxyurea treatmentFabia Neves, Osvaldo Alves Menezes Neto, Larissa Bueno Polis, et al.
Pageof 4